|
Chris Bingefors PhD, MSc
Department of Pharmacy;
Pharmacoepidemiology & PE
Uppsala University
E-Mail: Chris.Bingefors@farmaci.uu.se
Benjamin Geisler, MD
Harvard School of Public Health and Beth Israel Deaconess Medical Center
E-mail: ben.geisler@gmail.com
John Hornberger, MD, MS
Cedar Associates LLC
Stanford University School of Medicine
E-mail: jhornberger@cedarecon.com
Adrian Levy
University of British Columbia
E-Mail: alevy@interchange.ubc.ca
Gordon G. Liu, PhD
Peking University Guanghua School of Management and UNC Chapel Hill
E-Mail: ggliu@unc.edu
Andrea Manca PhD, MSc
Centre for Health Economics, University of York, Alcuin A, York, UK
Email: am126@york.ac.uk |
|
C. Daniel Mullins, PhD
University of Maryland
E-Mail: dmullins@rx.umaryland.edu Michelle Naughton, PhD
Wake Forest University School of Medicine
Division of Public Health Sciences
E-Mail: naughton@wfubmc.edu
Paul Scuffham PhD, BA
Griffith University - School of Medicine
Email: p.scuffham@griffith.edu.au
Johan L. Severens PhD,
University Maastricht, Dept. of Health Organisation, Policy, and Economics
E-mail: h.severens@beoz.unimaas.nl
Ulla S. Skjoldborg PhD, MA
Email: ulla@skjoldborg.biz
Sean Sullivan, PhD
University of Washington,
Department of Pharmacy
E-Mail: sdsull@u.washington.edu |
|
Marc L. Berger, MD
Eli Lilly and Company
Indianapolis, IN
Email: bergerma@lilly.com
Andrew Briggs, DPhil
University of Glasgow
Glasgow, United Kingdom
Email: a.briggs@clinmed.gla.ac.uk
DS Pete Fullerton PhD
Strategic Pharmacy Innovations
Seattle, WA
Email: peteful@msn.com
Jean Paul Gagnon, PhD
sanofi aventis
Parsippany, NJ
Email: Jean.Gagnon@aventis.com
Henry Glick
University of Pennsylvania
Philadelphia, PA
Email: hlthsvrs@mail.med.upenn.edu
Paul Kind, MPhil
Quality Outcomes
York, UK
Email: pk1@york.ac.uk
Paul C. Langley, PhD
University of Minnesota
Woodbury, MN
Email: P8366@MSN.comPablo Lapuerta, MD
Bristol-Myers Squibb
Princeton, NJ
Email: pablo.lapuerta@bms.com
Steven E. Marx, PharmD, MS
Pharmaceutical Products Group
Global Health Economics & Outcomes Research
Abbott Park, IL
Email: Steve.marx@abbott.com
Karl A. Matuszewski, MS, PharmD
Univ Health System Consortium
Oak Brook, IL
Email: matuszewski@uhc.edu
William F. McGhan, PharmD, PhD
University of the Sciences in Philadelphia
Philadelphia, PA
Email: w.mcghan@usip.edu |
|
Richard J. Milne, PhD
University of Auckland
Auckland, New Zealand
Email: rj.milne@auckland.ac.nz Louis A. Morris, PhD
Louis A. Morris & Associates
Dix Hill, NY
Email: lmorris@optonline.net.com
Peter Neumann, ScD
Tufts-New England Medical Center
Email: pneumann@tuftsmedicalcenter.org
Mark Nuijten MD, Chair
IMTA
Rotterdam, The Netherlands
E-Mail: marknuijten@planet.nl
David Paltiel, PhD
Yale School of Medicine
New Haven, CT
E-Mail: david.paltiel@yale.edu
Chris L. Pashos, PhD
Abt Bio-Pharma Solutions, Inc. - HERQuLES
Lexington, MA
Chris.Pashos@abtbiopharma.com
Dennis Revicki, PhD
UBC
Bethesda, MD
Email: dennis.revicki@unitedbiosource.com
Kevin A. Schulman, MD
Duke Clinical Research Institute
Durham, NC
Email: schul012@mc.duke.edu
George W. Torrance, PhD
McMaster University
Toronto, ON
Email: torrance@mcmaster.ca
Milton C. Weinstein, PhD
Harvard School of Public Health
Boston, MA
Email: mcw@hsph.harvard.edu |
